UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model

Oncogene, 2021-01, Vol.40 (2), p.396-407

2021

Volltextzugriff (PDF)

Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function

Nature immunology, 2013-06, Vol.14 (6), p.543-553

2013

Volltextzugriff (PDF)

Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells

Proceedings of the National Academy of Sciences - PNAS, 2015-12, Vol.112 (49), p.15154-15159

2015

Volltextzugriff (PDF)

An efficient siRNA‐mediated gene silencing in primary human monocytes, dendritic cells and macrophages

Immunology and cell biology, 2014-09, Vol.92 (8), p.699-708

2014

Volltextzugriff (PDF)

Dectin-1-Dependent LC3 Recruitment to Phagosomes Enhances Fungicidal Activity in Macrophages

The Journal of infectious diseases, 2014-12, Vol.210 (11), p.1844-1854

2014

Volltextzugriff (PDF)

Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages

PloS one, 2008-01, Vol.3 (1), p.e1403-e1403

2008

Volltextzugriff (PDF)

A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis

The Journal of experimental medicine, 2009-09, Vol.206 (10), p.2205-2220

2009

Volltextzugriff (PDF)

205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A216-A216

2021

Volltextzugriff (PDF)

Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture

iScience, 2024-03, Vol.27 (3), p.109006, Article 109006

2024

Volltextzugriff (PDF)

C-type lectins in immune defense against pathogens: the murine DC-SIGN homologue SIGNR3 confers early protection against Mycobacterium tuberculosis infection

Virulence, 2010-07, Vol.1 (4), p.285-290

2010

Volltextzugriff (PDF)

Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens

Cancer cell, 2018-06, Vol.33 (6), p.1033-1047.e5

2018

Volltextzugriff (PDF)

Abstract 1878: Fc-enhanced anti-CTLA-4 antibody, AGEN1181: new mechanistic insights for potent antitumor immunity and combination potential in treatment-resistant solid tumors

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1878-1878

2021

Volltextzugriff (PDF)

Dectin-1-Dependent LC3 Recruitment to Phagosomes Enhances Fungicidal Activity in Macrophages

The Journal of infectious diseases, 2014-12, Vol.210 (11), p.1844-1854

2014

Volltextzugriff (PDF)

C-type lectins in immunity to Mycobacterium tuberculosis

Frontiers in bioscience (Scholar edition), 2011, Vol.S3 (1), p.1147

Tanne, Antoine

2011

Volltextzugriff (PDF)

Abstract 922: Expanding the therapeutic potential of anti-PD-1 and anti-CTLA-4 therapy with innovative Fc engineering and rationale combinations for the treatment of solid tumors

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.922-922

2020

Volltextzugriff (PDF)

Abstract 531: The landscape of immunostimulatory RNA transcription

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.531-531

2016

Volltextzugriff (PDF)

Dectin-1 Activation Controls Maturation of β-1,3-Glucan-containing Phagosomes

The Journal of biological chemistry, 2013-05, Vol.288 (22), p.16043-16054

2013

Volltextzugriff (PDF)

C-type lectins in immunity to Mycobacterium tuberculosis

Frontiers in bioscience (Scholar edition), 2011-06, Vol.3 (3), p.1147-1164, Article 217

2011

Volltextzugriff (PDF)

Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy

Cancer discovery, 2024-07, p.OF1-OF23

2024

Volltextzugriff (PDF)

Natural pattern-recognition-receptor agonists in prophylactic vaccines for in situ vaccination of lymphoma

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14516-e14516

2016

Volltextzugriff (PDF)

Abstract 2721: Selective FcγR engagement by CTLA-4 antibodies results in increased functional activity

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2721-2721

2018

Volltextzugriff (PDF)

Neoantigen Synthetic Peptide Vaccine for Multiple Myeloma Elicits T Cell Immunity in a Pre-Clinical Model

Blood, 2017-12, Vol.130, p.1868-1868

2017

Volltextzugriff (PDF)

Abstract 4609: Agenus’ next generation cancer vaccine platforms

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4609-4609

2017

Volltextzugriff (PDF)

Abstract 3654: AGEN1884, an IgG1 anti-CTLA-4 antibody, combines effectively with PD-1 blockade in primary human T cell assays and in a non-human primate pharmacodynamic (PD) model

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3654-3654

2017

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(28)

Publikationsform

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model

Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function

Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells

An efficient siRNA‐mediated gene silencing in primary human monocytes, dendritic cells and macrophages

Dectin-1-Dependent LC3 Recruitment to Phagosomes Enhances Fungicidal Activity in Macrophages

Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages

A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis

205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models

Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture

C-type lectins in immune defense against pathogens: the murine DC-SIGN homologue SIGNR3 confers early protection against Mycobacterium tuberculosis infection

Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens

Abstract 1878: Fc-enhanced anti-CTLA-4 antibody, AGEN1181: new mechanistic insights for potent antitumor immunity and combination potential in treatment-resistant solid tumors

Dectin-1-Dependent LC3 Recruitment to Phagosomes Enhances Fungicidal Activity in Macrophages

C-type lectins in immunity to Mycobacterium tuberculosis

Abstract 922: Expanding the therapeutic potential of anti-PD-1 and anti-CTLA-4 therapy with innovative Fc engineering and rationale combinations for the treatment of solid tumors

Abstract 531: The landscape of immunostimulatory RNA transcription

Dectin-1 Activation Controls Maturation of β-1,3-Glucan-containing Phagosomes

C-type lectins in immunity to Mycobacterium tuberculosis

Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy

Natural pattern-recognition-receptor agonists in prophylactic vaccines for in situ vaccination of lymphoma

Abstract 2721: Selective FcγR engagement by CTLA-4 antibodies results in increased functional activity

Neoantigen Synthetic Peptide Vaccine for Multiple Myeloma Elicits T Cell Immunity in a Pre-Clinical Model

Abstract 4609: Agenus’ next generation cancer vaccine platforms

Abstract 3654: AGEN1884, an IgG1 anti-CTLA-4 antibody, combines effectively with PD-1 blockade in primary human T cell assays and in a non-human primate pharmacodynamic (PD) model

Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulation

Suchergebnisse filtern